Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Wie wirkt sich bariatrische Chirurgie auf soziale Erfahrungen und Wohlbefinden aus - Die BaSES-Studie (BaSES)

17. September 2026 aktualisiert von: Jøran Hjelmesæth, The Hospital of Vestfold

Wie Magenbypass und Sleeve-Gastrektomie soziale Erfahrungen und Biomarker des Wohlbefindens verändern

Nonrandomized controlled trial to assess whether or not sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) affect social experiences and biomarkers of well-being 6 weeks and 1 year after surgery. The decision whether SG or RYGB will be performed is determined by medical decision making. Hypotheses: Bariatric surgery influences social experiences and well-being through changes in body image, reward responsivity and gut hormones. These changes may differ between gastric bypass (RYGB) and sleeve gastrectomy (SG).

Studienübersicht

Detaillierte Beschreibung

Explanation for choice of comparators

Obesity is one of the world's most serious public health problems. Conservative weight reduction methods alone (diet, exercise) often show disappointing results, as the majority of people who lose weight regain it after a shorter or longer period of time. The currently most effective measure to achieve a durable weight-loss is bariatric surgery.

When investigating the effectiveness of bariatric surgery, the focus has most often been on weight loss and obesity-related complications, while effects on social interaction and subjective experience have received much less attention. A large body of evidence has demonstrated that (supportive) social relationships benefit health. Individuals with low compared to those with high levels of social connectedness are more likely to die prematurely; and social relationships can also affect a range of other health conditions such as cardiovascular disease, cancer, and immune function. Importantly, individuals with obesity may experience social interactions as less positive than normal-weight individuals. They recount avoiding social events and relationships, but also career opportunities, shopping and other activities where they feel observed because of weight stigma. Such avoidance behavior can lead to a "chronic disengagement" with many aspects of social life, which in turn might decrease interpersonal skills. Further investigations into the link between social behavior and eating found that greater emotional eating is associated with greater social avoidance. Eating was described a means to cope with loneliness on the one hand, while on the other hand aggravating feelings of being alone due to the stigma associated with obesity. This way, loneliness and obesity can create a vicious circle. In terms of how bariatric surgery influences social interactions, one 10-year follow up study found improvements in social interactions for bariatric surgery, but not for conventional weight loss treatment. In qualitative studies, many participants mentioned that they received more positive social feedback following bariatric surgery, and that they enjoyed social activities more than before, although they also describe ambiguous feelings.

The present study will investigate whether and how two types of bariatric surgery improve the response to a range of social aspects of patients' daily lives. Further, it aims to determine potential mechanisms leading to these effects, namely changes in body image, gut hormones, and reward responsivity.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

134

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Vestfold
      • Tønsberg, Vestfold, Norwegen, 3103
        • Morbid Obesity Center

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • scheduled for bariatric surgery and eligible for sleeve gastrectomy or gastric bypass
  • able to give consent
  • understand written and spoken Norwegian

Exclusion Criteria:

  • pregnancy and breast-feeding
  • chronic disease (endocrine, heart, neurological, lung, gastrointestinal, kidney)
  • cancer
  • acute psychotic episode

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Gastric bypass

Gastric bypass

In Roux-en-Y gastric bypass (RYGB), the left crus will be dissected free, any hiatal hernia left in place. The minor curvature is opened at the second vessel and the lesser sac entered. A 25 mL gastric pouch will be created by firing one horizontal and two vertical staple loads. The ligament of Treitz is then identified and a proximal loop of small intestine anastomosed to the pouch 60 cm from the ligament of Treitz with one linear stapler (full length of the stapler), creating an antecolic, antegastric alimentary limb. The opening will be closed using a single row, running absorbable suture. An entero-enteroanastomosis will be made 120 cm distal of the gastro-enteroanastomosis. The introductory opening is closed with a single row, running absorbable suture. The small intestine will be divided with one load between the gastro-entero-enteroanastomosis and the entero-enteroanastomosis in order to complete a bypass with an alimentary limb of 120 cm and a biliopancreatic limb of 60 cm.

Aktiver Komparator: Sleeve gastrectomy

Sleeve gastrectomy

In sleeve gastrectomy (SG) a large part (80%) of the ventricle is removed. The greater curvature will be dissected free starting 4-5 cm from the pylorus up to the angle of Hiss. The left crus is then visualized and inspected for hiatal hernia. Small sliding hernias and wide hiatus are left in situ. The ventricle will then be lifted and any adhesions in the lesser sac divided. A 35 Fr bougie is placed down to the pylorus guiding the creation of a tubular sleeve with linear staplers. The first two loads are always green or purple, while blue or tan loads are used for the rest of the ventricle. The last stapler is placed 5 mm laterally to the angle of Hiss. The staple line will then be inspected and secured with clips for additional haemostasis, no oversewing or buttressing material is routinely used.

Experimental: Single anastomosis sleeve ileal (SASI) bypass

Exploratory small arm with a small number of particpants

The SASI bypass will performed with a similar entry of the abdominal cavity. A 6-port set up and a liver retractor is utilized. The small bowel is measured 300cm from the ileocecal valve, in sequences of 10cm, with the small bowel stretched and markers placed on the graspers, and connected to the antrum of the stomach with a 45mm stapler. The anastomosis is positioned slightly ventral on the antrum. The antrum is opened ventrally 5 cm proximal to the pylorus, just below the horizontal axis of canalis pylori. A 12 mm port positioned left to the midline is used for introduction of the stapler, which is directed distally from the patient's left to right side. 2.5 cm of the 45 mm stapler device is used for firing the anastomosis, which is completed with a 2-0 PDS running suture. The fascia defect is closed for the port where the specimen is extracted. The mesenteric defect is not closed.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
1-year changes in Social Experience
Zeitfenster: Change from 4 weeks before surgery to 1 year after surgery

10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

Change from 4 weeks before surgery to 1 year after surgery

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Changes in affect ratings after social evaluation (inclusion and exclusion)
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Positive and Negative Affect Schedule (PANAS): The PANAS is a self-report measure that is made up of two mood scales of 10 adjectives each, one measuring positive affect and the other one measuring negative affect. (1) Positive Affect Scale (range: 10-50; higher values indicate higher positive affect); (2) Negative Affect Scale (range: 10-50, higher values indicate higher negative affect)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in experience ratings after social evaluation (inclusion and exclusion)
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Need-Threat Scale: 4 sub-scales: (1) Belonging, (2) Self-Esteem, (3) Meaningful existence, (4) Control; range: 3-27 per sub-scale; higher values indicate more belonging, higher self-esteem, higher meaningful existence, and more control)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in pleasantness ratings in response to touch stimulation on the forearm
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented visual analogue scale (VAS) scale: range 0-100 (unpleasant - pleasant) after a touch stimulation to the forearm (repeated 10 times)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in pleasantness ratings in response to self-stroking on the forearm
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (unpleasant - pleasant), after participants made 10 back-and-forth strokes on their forearm with their hand

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in intensity ratings in response to touch stimulation on the forearm
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after a touch stimulation to the forearm (repeated 10 times)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in intensity ratings in response to self-stroking on the forearm
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after participants made 10 back-and-forth strokes on their forearm with their hand

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in self-stroking velocity
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Participants are instructed to stroke their own forearm with a velocity they experience as pleasant. The duration of 10 back-and-forth strokes over a 10 cm distance on the forearm will be measured with a stop watch. Velocity in cm/sec will be calculated thereafter.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in cortisol levels from hair samples
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Cortisol (in pg/mg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in endocannabinoid levels from hair samples
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Endocannabinoids (in pg/mg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in fasting ghrelin levels from blood samples
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Ghrelin (in pg/ml)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in body image
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaires: Appearance Evaluation Scale (AES) and the Body Areas Satisfaction Scale (BASS) - the AES was designed to measure overall satisfaction/dissatisfaction with one's appearance and physical attractiveness. It has 7 items (range: 5-35) with high scores indicating body satisfaction and low scores indicating body dissatisfaction. The BASS was designed to measure the degree of dissatisfaction-satisfaction with specific body areas and attributes (range: 9-45). Higher scores indicate greater body satisfaction and lower scores indicate greater body dissatisfaction.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in reward responsivity
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Temporal Experience of Pleasure Scale (TEPS) - the TEPS was designed to measure individual trait dispositions in both anticipatory and consummatory experiences of pleasure. It consists of 18 items, of which 10 form the (1) anticipatory pleasure scale (range: 10-60), and (2) 8 items for the consummatory pleasure scale (range: 8-48). Higher values on (1) indicate enhanced reward responsiveness and imagery, while higher values on (2) indicate higher openness to different experiences and appreciation of positive stimuli.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in interoceptive ability
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Body Awareness Questionnaire (BAQ) - the BAQ was designed to assess self-reported attentiveness to normal nonemotive body processes, such as sensitivity to body rhythms, ability to detect small changes in normal bodily functioning, and one's ability to anticipate bodily reactions. It consists of 18 items (range: 18-126). Higher values indicate a higher sensitivity and awareness of one's bodily states.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in belongingness
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaires: The Social Connectedness Scale Revised (SCS-R) and the Social Assurance Scale (SAS). The SCS-R was designed to measure a psychological sense of belonging, or how individuals cognitively construe interpersonal closeness with others in their social world. It consists of 20 items (range: 20-120), with higher values indicating a higher sense of belonging. The SAS was designed to measure the importance of assurance from one's social group.It consists of 8 items (range: 8-48), with higher values indicating a higher need for social assurance.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in social network size
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: The Social Network Index (SNI) - the SNI was designed to measure three aspects of one's social networks: (1) network diversity, (2) number of people in the network, and (3) number of embedded networks. Each of the three sub-scales is assessed on 12 items. (1) refers to the number of high-contact roles (range: 0-12), with higher values indicating a higher number of social roles. (2) refers to the total number of people with whom the respondent has regular contact, which will be summed for the 12 items (range: 0-70). Higher numbers indicate more people in one's network (to not inflate the number, items 4-12 will be scored with 7 in case the reported number of people in this group is equivalent or larger to 7). The embedded network scale (3) reflects the number of different network domains in which a respondent is active (range: 0-8), with higher numbers indicating activity in more network domains.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in self-reported eating patterns
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire:The Three Factor Eating Questionnaire -R 21 (TFEQ-R21) measures eating behaviour and has been validated for use in individuals with obesity and will be used in the study. It consists of 21 items comprising three domain scores; (1) uncontrolled eating; assessing the tendency to lose control over eating when feeling hungry or when exposed to external stimuli, (2) cognitive restraint; assessing the conscious restriction of food intake to control body weight or body shape, and (3) emotional eating; assessing overeating related to negative mood states. The domain scores were transformed to 0-100 scales to facilitate comparison; a higher score indicates more uncontrolled, restraint, or emotional eating.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in symptoms of depression and anxiety
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Hospital Anxiety and Depression Scale (HADS). The validated generic HADS measures symptoms of anxiety and depression using 14 items scored from 0-3 It is decomposed into two domains measuring depression (HADS-D) and anxiety (HADS-A), both consisting of seven items yielding a score from 0-21.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 1
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Generic questionnaire: Short Form-36 Health Survey (SF-36). Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores for each of the 8 domains and summary scores for physical and mental health will be calculated.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 2
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Questionnaire: Weight-related Symptom Measure (WRSM). The validated obesity specific WRSM measures 20 symptoms commonly related to being overweight or obese, including foot problems, joint pain, sensitivity to cold, shortness of breath, etc. using two different sets of items. The first set assesses whether or not a patient is experiencing specific symptoms, and the second set rates the level of the distress of the symptoms with values from zero ("not at all") to six ("bothers a very great deal"). The first set creates an additive scale summing symptoms from 0-20, while the second forms a symptom distress scale ranging from 0-120.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Changes in Health Related Quality of Life 3
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Obesity specific questionnaire: The Impact of Weight on Quality of Life-Lite (IWQOL-lite). The IWQOL-Lite is a 31-item measure of weight-related quality of life. There are five domain scores (Physical Function, Self-Esteem, Sexual Life, Public Distress and Work) and a total score. Scores for all domains and total score range from 0-100, with lower scores indicating greater impairment.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
6-week Changes in Social Experience
Zeitfenster: Change from 4 weeks before surgery to 6 weeks after surgery

10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

Change from 4 weeks before surgery to 6 weeks after surgery
Group differences between SG and RYBG patients in the above-mentioned outcomes [1-22]
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

The above-mentioned outcomes will be tested for differences between the two surgery types.

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Body Mass Index (BMI)
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

calculated from height (in cm) and weight (in kg) as kg/m^2

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in weight
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Percent total weight loss (%TWL) and in kg

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in anthropometric measures
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Waist and hip circumference (cm)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in body fat
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Body fat (in %)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in fat-free mass
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Fat-free mass (in kg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in blood pressure
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Systolic and diastolic blood pressure (mm/Hg)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in lipids
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Total-cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (all in mmol/l)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in glucose parameters
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

HbA1c (mmol/mol); C-peptide (nmol/l)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in C-reactive protein (CRP)
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

CRP (mg/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in blood enzymes
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

ASAT (aspartate aminotransferase), ALAT (alanine-aminotransferase), LD (lactate dehydrogenase), Gamma-GT (gamma-glutamyl transferase), ALP (alkaline phosphatase) (all in U/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in hemoglobin
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Hemoglobin (g/100 ml)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery
Change in ferritin
Zeitfenster: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Ferritin ((µg/L)

Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Mitarbeiter

Ermittler

  • Hauptermittler: Jøran Hjelmesæth, Professor, The Hospital of Vestfold

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

12. Mai 2022

Primärer Abschluss (Tatsächlich)

5. November 2025

Studienabschluss (Tatsächlich)

5. November 2025

Studienanmeldedaten

Zuerst eingereicht

8. Dezember 2021

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

12. Januar 2022

Zuerst gepostet (Tatsächlich)

26. Januar 2022

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

22. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

17. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-anonymized individual participant data can be made available following publication upon reasonable request to authors Jøran Hjelmesæth and Uta Sailer. Data will be shared according to the consent given by the participants and Norwegian laws and legislation.

IPD-Sharing-Zeitrahmen

For at least 10 years after publication

IPD-Sharing-Zugriffskriterien

All requests must be handled within the legal framework of Norway; non-commercial use of de-anonymized data

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren